Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany

  • Florian Schwarz,
  • Habibollah Arefian,
  • Michael Hartmann,
  • Ingo Runnebaum

There is an error in affiliation 5 for author Ingo Runnebaum. The correct affiliation 5 is: Cancer Center Central Germany, Jena, Germany.

Reference

  1. 1. Schwarz F, Arefian H, Hartmann M, Runnebaum I (2022) Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany. PLoS ONE 17(12): e0278460. pmid:36454738

Citation: Schwarz F, Arefian H, Hartmann M, Runnebaum I (2024) Correction: Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany. PLoS ONE 19(5): e0303776. https://doi.org/10.1371/journal.pone.0303776

Published: May 9, 2024

Copyright: © 2024 Schwarz et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.